Peduncular Hallucinosis

Peduncular hallucinosis is a rare brain condition that causes vivid, detailed visual hallucinations. People often see bright, colorful, moving scenes, people, animals, or small figures. The person is awake and alert during the hallucination. Many people know the images are not real, or they can be persuaded that the images are not real.
The problem usually comes from damage or irritation in the midbrain or the thalamus, which are deep parts of the brain that help control vision, attention, and sleep-wake cycles. EyeWiki Doctors first described this syndrome about a century ago. Classic reports note bright, lifelike images, often worse in the evening or at night, in patients with midbrain or thalamic lesions and otherwise clear thinking. The Journal of NeurosurgeryPsychiatry Online

Peduncular hallucinosis is a neurological hallucination syndrome caused by damage or dysfunction around the cerebral peduncles (midbrain) and nearby thalamus. People with PH stay alert and oriented, and insight is often preserved—they usually know the images are unreal—but the scenes are vivid, colorful, and animated. Episodes often begin in the evening or in darkness, may last minutes to hours, and can recur over days or weeks. PH is a localizing clue to deep brain lesions and is different from psychiatric hallucinations because consciousness and thinking are otherwise clear, and from Charles Bonnet syndrome because there is usually a deep brain lesion rather than eye-only disease. EyeWikiPMCAmerican Academy of Neurology

Why does it happen?

The midbrain and thalamus sit in the center of the brain. They connect vision pathways with arousal and sleep circuits. When a stroke, bleed, tumor, inflammation, or other injury hits these areas, the normal balance between vision processing and sleep-dream circuits can be disturbed. Doctors think the injury may let REM-like dream activity leak into wakefulness, creating real-seeming images even though the eyes are open. Key circuits for wakefulness and REM sleep live in the upper brainstem (including the pedunculopontine region) and reticular formation. Damage around these circuits can trigger hallucinations while the person stays conscious. Oxford AcademicNCBIFrontiersPhysiology Journals

Peduncular hallucinosis (PH) is a rare neurological condition where a person sees vivid, lifelike visual scenes—often people, animals, or complex moving images—while fully awake and usually aware they aren’t real. PH most often follows an injury or disease affecting the midbrain (cerebral peduncles) and/or nearby thalamus, the deep “relay” structures that help control arousal, vision processing, and the sleep–wake cycle. EyeWikiPMCAmerican Academy of Neurology

These hallucinations tend to be colorful, detailed, and occur in dim light or at night, sometimes alongside brainstem symptoms like double vision or droopy eyelid if nearby nerves are affected. Episodes can recur for days to months and may fade as the brain heals or the underlying cause is treated. PMCEyeWiki

Types of peduncular hallucinosis

You can group PH in a few simple ways:

1) By location of the lesion

• Midbrain-based PH. This is the classic type. The lesion is in or near the cerebral peduncles or midbrain tegmentum. EyeWiki

• Thalamic-based PH. The lesion is in the thalamus or nearby structures and disrupts visual and arousal relays. PMC

• Pontine-adjacent PH. Less common, but lesions in the pons can also produce similar hallucinations when pathways are affected. BNR Brain & Neurorehabilitation

2) By cause

• Vascular PH. From ischemic stroke, small infarcts, or hemorrhage in the midbrain/thalamus; this is the most reported cause. PMC

• Structural PH. From tumors, cavernous malformations, or compressive masses. PMC

• Inflammatory or infectious PH. From infections or autoimmune inflammation that strike the brainstem or thalamus. PMC

• Post-surgical or post-traumatic PH. From operations or trauma near the midbrain-thalamic region. Wikipedia

3) By time course

• Acute PH. Starts suddenly after a stroke or hemorrhage.

• Subacute PH. Develops over days to weeks with infections or inflammation.

• Chronic or relapsing PH. Persists or returns if the underlying lesion or circuit problem continues.

4) By insight

• PH with preserved insight. The person understands the images are unreal (very common in PH).

• PH with partial insight. The person is unsure and needs reassurance.

Causes of peduncular hallucinosis

Below are common and plausible causes centered on injuries that disrupt midbrain-thalamic networks. I explain each in plain terms.

1. Ischemic stroke of the midbrain. A clot or small vessel blockage reduces blood flow and injures vision–arousal pathways. PMC

2. Ischemic stroke of the thalamus. A small thalamic infarct can trigger vivid images by disturbing visual relays and sleep-wake connections. PMC

3. Pontine stroke affecting ascending pathways. Damage below the midbrain can interrupt signals traveling upward and cause PH-like hallucinations. BNR Brain & Neurorehabilitation

4. Intracerebral hemorrhage in the brainstem. Bleeding irritates tissue and disrupts circuits that keep dreams separate from wakefulness. BNR Brain & Neurorehabilitation

5. Cavernous malformation in the midbrain. These low-flow vascular tangles can bleed or press on nearby tissue and trigger symptoms.

6. Brain tumors near the midbrain or thalamus. Tumors (glioma, meningioma, metastasis) can compress or infiltrate key pathways and cause complex visuals. PMC

7. Post-operative change near the suprasellar or midbrain region. Surgical manipulation can irritate tissues and unmask hallucinations until circuits stabilize. Wikipedia

8. Traumatic brainstem injury. A blow to the head can bruise the midbrain or its connections and lead to hallucinations during recovery.

9. Infectious encephalitis involving brainstem/thalamus. Viruses or bacteria inflame deep structures and disturb arousal and visual networks. PMC

10. Autoimmune encephalitis with diencephalic involvement. Immune attack can alter thalamic circuits and produce complex visuals.

11. Multiple sclerosis or other demyelinating disease. Plaques in the midbrain or thalamus can cause transient or recurrent hallucinations when pathways misfire.

12. Basilar tip aneurysm or vertebrobasilar dolichoectasia compressing the midbrain. Pulsatile pressure on the peduncles can provoke PH-like events.

13. Wernicke encephalopathy hitting the midline thalamus. Severe thiamine deficiency can affect the thalamus and produce visual phenomena.

14. Neurosarcoidosis or other granulomatous disease of the brainstem. Inflammation and mass effect disturb local circuits.

15. Paraneoplastic brainstem encephalitis. Cancer-related immune responses can damage REM-wake control centers.

16. Migraine with brainstem aura (rare trigger). Severe attacks affecting the brainstem may transiently produce complex visuals that resemble PH.

17. Posterior reversible encephalopathy with deep structure involvement. Blood-pressure swings and edema can touch visual relays.

18. Toxic injury that targets the brainstem (rare). Certain toxins or overdoses can injure arousal nuclei.

19. Sleep-wake disorders that interact with a subtle lesion. A small lesion plus narcolepsy-like physiology can allow dream imagery to intrude into wakefulness. Frontiers

20. Radiation or chemotherapy injury to midbrain/thalamus (rare). Treatment-related damage to deep structures may trigger persistent visuals.

Note: Across case series, vascular lesions (strokes and small bleeds) are reported as the most frequent cause of PH, especially in the midbrain and thalamus. PMC

Symptoms

1. Vivid, colorful visual hallucinations. People see lifelike scenes, people, or animals in bright color and motion. EyeWiki

2. Preserved clarity of thinking. The person is awake, knows where they are, and can answer questions during the hallucination. The Journal of Neurosurgery

3. Often good insight. Many recognize the images are not real or accept gentle correction. ScienceDirect

4. Evening or nighttime worsening. Hallucinations may increase in low light or around bedtime. Psychiatry Online

5. Short episodes that recur. Events can last minutes to hours and repeat over days or weeks.

6. Neutral or curious emotional reaction. The person may be surprised or amused rather than terrified.

7. No command content. The images rarely “order” the person to act.

8. No strong delusions. Beliefs stay mostly intact, unlike psychosis.

9. Possible sleep disturbance. Insomnia, REM behavior-like symptoms, or dream-wake mixing may appear. Frontiers

10. Visual clarity varies. Some images are sharp and detailed; others are foggy or small (“lilliputian”). ScienceDirect

11. Coexisting neurologic signs from the lesion. There may be double vision, droopy eyelid, pupil changes, weakness, or unsteady gait depending on the lesion site.

12. Headache or dizziness. These can occur when vascular or inflammatory causes are active.

13. Fatigue and daytime sleepiness. Disrupted arousal circuits can cause tiredness. Frontiers

14. Anxiety about the cause. People often worry about “going crazy,” even though PH is a neurological syndrome.

15. Gradual improvement as the lesion heals. Many cases ease as swelling resolves or as the brain adapts over weeks to months. BNR Brain & Neurorehabilitation

Diagnostic tests

Clinicians use tests to confirm a brain lesion, exclude look-alike conditions, and check sleep-wake and eye-brain pathways.
Below are 20 tests grouped into 5 categories with simple descriptions.

A) Physical examination

1. General neurologic exam. The doctor checks speech, strength, sensation, coordination, reflexes, and walking. This finds signs of a brainstem or thalamic lesion that support PH over a primary psychiatric cause.

2. Cranial nerve exam. The doctor looks for double vision, droopy eyelids, abnormal pupils, facial weakness, or swallowing problems. Findings can point to the midbrain or pons as the source, which fits PH.

3. Mental status and orientation exam. The clinician confirms that the person is awake, oriented, and thinking clearly. Preserved attention and orientation help separate PH from delirium or psychosis.

4. Eye and visual field exam. Vision acuity and fields are checked to see if the eyes and optic nerves work normally. Normal eye structure with complex visuals favors a central brain cause like PH over an eye disease.

B) Bedside “manual” neurologic tests

5. Smooth pursuit and saccade testing. The examiner watches how the eyes track a target and make quick jumps. Abnormal tracking can signal a midbrain or pontine problem supporting PH.

6. Cover-uncover and alternate cover tests. These look for subtle eye misalignment that can arise with brainstem lesions. Misalignment plus hallucinations strengthens a central cause.

7. Head-impulse (vestibulo-ocular) test. This quick test checks vestibular-eye reflexes. Unexpected findings can point to brainstem involvement, which matches PH’s usual lesion sites.

8. Gait, Romberg, and limb coordination tests. Heel-toe walking, standing with eyes closed, finger-to-nose, and rapid alternating movements can show cerebellar or brainstem involvement often near the regions tied to PH.

C) Laboratory and pathological tests

9. Complete blood count and metabolic panel. These basic labs look for anemia, infection, electrolyte or kidney issues. While not specific, they rule out metabolic delirium that can mimic hallucinations.

10. Inflammation and infection markers (ESR/CRP; cultures; serologies). These tests look for systemic or CNS infection or inflammation that could affect the brainstem or thalamus and imitate or cause PH. PMC

11. Autoimmune and paraneoplastic panels (when suspected). Antibody tests can detect autoimmune encephalitis or cancer-related immune attacks on deep brain structures.

12. Cerebrospinal fluid (CSF) analysis (if safe and indicated). A lumbar puncture can show infection, inflammation, or malignant cells if those causes are suspected.

D) Electrodiagnostic tests

13. Electroencephalogram (EEG). EEG checks for seizures or epileptiform activity. Most PH patients have a normal EEG during hallucinations, which helps separate PH from occipital lobe seizures. Psychiatry Online

14. Polysomnography (overnight sleep study). A sleep study can show REM intrusions, dream-wake mixing, or REM behavior patterns that align with the REM-circuit hypothesis in PH. Frontiers

15. Visual evoked potentials (VEPs). VEPs test the electrical response from the eye to the visual cortex. Normal VEPs with complex images favor a central integration problem rather than a damaged optic pathway.

16. Brainstem auditory evoked responses (BAER). BAERs check brainstem conduction. Abnormal results support a brainstem lesion that might underlie PH.

E) Imaging tests

17. MRI of the brain with diffusion-weighted imaging. This is the key test. MRI can show a midbrain or thalamic infarct, hemorrhage, or other lesion connected to PH. PMC

18. MR angiography or CT angiography. Vessel imaging looks for vertebrobasilar stenosis, occlusion, aneurysm, or malformation affecting midbrain/thalamic blood supply.

19. CT of the head. A fast CT can show acute bleeding or a mass if MRI is not immediately available. It is also used to guide urgent stroke care.

20. Targeted imaging follow-up (contrast MRI, perfusion, or PET/SPECT when needed). These help clarify tumor, inflammation, or metabolic patterns if the initial MRI is uncertain. Radiologists use structured approaches because visual hallucinations often point to “organic” brain disease that imaging can reveal. PMC

Non-pharmacological treatments

Note: These approaches aim to reduce triggers, shorten episodes, lower anxiety, and improve safety. They complement medical care.

1. Condition & cause education
   Description: A clinician explains PH, typical triggers, and recovery expectations.
   Purpose: Reduce fear and stigma; improve cooperation with care.
   Mechanism: Knowledge re-labels the experience as a brain symptom (not “going crazy”), which lowers arousal and secondary anxiety that can amplify hallucinations. PMC

2. Sleep hygiene reset
   Description: Fixed bed/wake times, wind-down routine, cool/dark bedroom, limited caffeine/alcohol late day.
   Purpose: Stabilize the sleep–wake switch.
   Mechanism: Reduces REM intrusion and drowsiness-related hallucinations. ScienceDirect

3. Evening light strategy
   Description: Use soft, steady ambient light and night-lights; avoid deep darkness and harsh shadows.
   Purpose: Cut visual misinterpretations in dim light.
   Mechanism: Better visual input reduces “fill-in” errors of the brain. PMC

4. Daytime bright-light exposure
   Description: Morning outdoor light or light-box (if advised).
   Purpose: Strengthen circadian rhythm for consolidated nighttime sleep.
   Mechanism: Entrains the suprachiasmatic clock; may reduce REM dysregulation. ScienceDirect

5. Reality-testing and grounding
   Description: When an image appears, blink, switch on brighter light, touch a solid object, or look at it from another angle.
   Purpose: Shorten episodes and reassure.
   Mechanism: Adds conflicting sensory input that helps the brain dismiss the false image. PMC

6. Cognitive-behavioral therapy for hallucinations (CBT-p principles)
   Description: Brief therapy focused on reducing distress and safety behaviors, and building coping scripts.
   Purpose: Improve control and reduce avoidance.
   Mechanism: Reframes appraisals (“this is my brain misfiring”), lowering arousal that maintains hallucinations. (Evidence extrapolated from CBT for hallucinations; no PH-specific RCTs.)

7. Mindfulness/relaxed breathing
   Description: Slow breaths, body scan, noticing without reacting.
   Purpose: Lower sympathetic surge during an episode.
   Mechanism: Reduces limbic arousal that can intensify perception.

8. Optimize vision
   Description: Up-to-date glasses, cataract check, low-vision aids if needed.
   Purpose: Improve incoming signals.
   Mechanism: Better retinal input reduces brain “fill-in” hallucinations. (Conceptual overlap with visual-deprivation hallucinosis.) EyeWiki

9. Environmental simplification
   Description: Remove visually busy patterns and flickering lights; keep clear pathways.
   Purpose: Reduce false pattern detection and improve safety.
   Mechanism: Fewer ambiguous stimuli to misinterpret.

10. Evening screen management
    Description: Dim warm screens, reduce fast-cut videos before bed.
    Purpose: Prevent arousal and visual after-images that can seed misperception.
    Mechanism: Limits visual persistence and catecholamine arousal.

11. Regular physical activity (as cleared by clinician)
    Description: Daily walking or therapy-guided exercises.
    Purpose: Improve sleep quality, mood, and vascular health.
    Mechanism: Enhances slow-wave sleep and neurotrophic factors.

12. Occupational therapy home-safety review
    Description: Check lighting, tripping hazards, and routines.
    Purpose: Prevent falls or injuries during startled reactions.
    Mechanism: Reduces environment-driven risk.

13. Treat coexisting sleep disorders non-pharmacologically
    Description: CPAP for obstructive sleep apnea, positional therapy, dental devices—if diagnosed.
    Purpose: Stabilize sleep architecture.
    Mechanism: Fewer arousals reduce REM intrusions. PMC

14. Headache/migraine trigger control
    Description: Hydration, regular meals, trigger diary.
    Purpose: Some PH cases follow brainstem vascular events; migraine control may reduce overlapping triggers.
    Mechanism: Stabilizes brainstem excitability.

15. Hydration and infection vigilance
    Description: Prompt fluids, treat fevers/UTIs through clinician.
    Purpose: Avoid delirium-like worsening of hallucinations when ill.
    Mechanism: Keeps metabolic stressors from lowering perception thresholds.

16. Caregiver coaching
    Description: Teach calm validation (“I believe you’re seeing that; you’re safe”).
    Purpose: Reduce panic and conflict.
    Mechanism: Lowers adrenergic amplification of episodes.

17. Scheduled, meaningful daytime activity
    Description: Light chores, social time, sunlight breaks.
    Purpose: Reduce daytime napping and boredom.
    Mechanism: Strengthens circadian rhythm; lowers ruminative attention on visuals.

18. Smoking cessation & alcohol moderation
    Description: Use counseling programs.
    Purpose: Protect vascular health and sleep quality.
    Mechanism: Reduces brainstem irritability and REM disruption.

19. Trigger diary
    Description: Log time, lighting, stress, sleep before episodes.
    Purpose: Personalize strategies.
    Mechanism: Identifies modifiable antecedents.

20. Gradual exposure to dim environments (with support)
    Description: Practice being in lower light using the above coping steps.
    Purpose: Build confidence and reduce avoidance.
    Mechanism: Habituation reduces conditioned anxiety.

---

Drug treatments

Important safety note: Doses below are typical adult starting ranges used off-label in case reports of PH or in related conditions (e.g., REM intrusion, complex visual hallucinations). Always follow your clinician’s individualized plan, especially if you have stroke, heart disease, diabetes, Parkinson’s, or are older/frail.

1. Olanzapine (atypical antipsychotic)
   Dose/Timing: 2.5–5 mg at bedtime; titrate cautiously.
   Purpose: Reduce frequency/intensity of hallucinations.
   Mechanism: 5-HT2A/D2 antagonism lowers pathologic visual salience.
   Side effects: Sleepiness, weight gain, metabolic changes, anticholinergic effects, rare EPS. Evidence: Several PH case reports showed improvement. MeridianPubMed

2. Quetiapine (atypical antipsychotic)
   Dose/Timing: 12.5–25 mg at bedtime; may increase to 25–100 mg/day.
   Purpose: Similar to olanzapine; often preferred in older adults due to lower EPS risk.
   Mechanism: 5-HT2A/D2 antagonism with sedative H1 action aiding sleep.
   Side effects: Sedation, orthostatic dizziness, metabolic effects. Evidence: PH cases—including one improved with quetiapine plus melatonin. PubMed+1

3. Risperidone (atypical antipsychotic)
   Dose/Timing: 0.25–0.5 mg at night; cautious titration.
   Purpose: Symptom control if first-line options fail.
   Mechanism: Potent D2/5-HT2A blockade.
   Side effects: EPS at higher doses, prolactin elevation, dizziness.

4. Clozapine (atypical antipsychotic; specialist use)
   Dose/Timing: Start 12.5–25 mg nightly; slow titration; requires ANC blood monitoring.
   Purpose: Refractory hallucinations.
   Mechanism: Broad 5-HT/D receptor profile; strong anti-hallucinatory effect.
   Side effects: Sedation, orthostasis, sialorrhea, agranulocytosis risk (requires monitoring).

5. Pimavanserin (5-HT2A inverse agonist; off-label)
   Dose/Timing: 34 mg once daily (standard in Parkinson’s psychosis).
   Purpose: Reduce complex visual hallucinations with minimal D2 blockade.
   Mechanism: Selective 5-HT2A modulation of visual salience pathways.
   Side effects: QT prolongation risk, edema, confusion (rare).

6. Clonazepam (benzodiazepine)
   Dose/Timing: 0.25–0.5 mg at bedtime; target 0.5–1 mg if tolerated.
   Purpose: If REM intrusion or parasomnia features are suspected.
   Mechanism: GABA-A enhancement stabilizes REM control and reduces arousals.
   Side effects: Daytime sedation, imbalance/falls, dependence with long use. Evidence: First-line symptomatic therapy for REM sleep behavior disorder (RBD). PMC

7. Melatonin (hormone; sometimes classed as supplement)
   Dose/Timing: 3–5 mg 1–2 hours before bed; some need 5–10 mg.
   Purpose: Normalize circadian timing and REM architecture.
   Mechanism: MT1/MT2 receptor action shifts circadian phase and stabilizes REM.
   Side effects: Morning grogginess, vivid dreams. Evidence: Used in PH cases and RBD literature; one PH case improved with quetiapine then nightly melatonin. PubMedPMC

8. Aspirin (antiplatelet) for ischemic cause
   Dose/Timing: 81–325 mg daily as prescribed.
   Purpose: Secondary stroke prevention when PH follows ischemic events.
   Mechanism: Irreversible COX-1 inhibition reduces platelet aggregation.
   Side effects: Bruising, GI upset/bleeding. (Etiologic therapy; standard stroke care.)

9. High-intensity statin (e.g., atorvastatin)
   Dose/Timing: Typical 40–80 mg nightly if indicated for stroke prevention.
   Purpose: Vascular protection after brain ischemia.
   Mechanism: Lowers LDL and stabilizes plaques; pleiotropic anti-inflammatory effects.
   Side effects: Myalgias, rare liver enzyme rise.

10. Antiepileptic—Carbamazepine (selected cases)
    Dose/Timing: 100–200 mg twice daily, if seizure-like phenomena or neuralgia-related irritability is suspected by a specialist.
    Purpose: Reduce paroxysmal brainstem excitability.
    Mechanism: Sodium-channel blockade.
    Side effects: Drowsiness, hyponatremia, rash; drug interactions. Evidence: Improvement reported after tumor resection plus carbamazepine in a PH case. PubMed

---

Dietary “molecular” supplements

Always review supplements with your clinician—especially if you take blood thinners, diabetes medicines, or antiepileptics. Evidence for PH-specific benefit is indirect; the aim is brain, sleep, and vascular support.

1. Omega-3 (EPA+DHA) — 1–2 g/day with meals
   Function: Vascular and anti-inflammatory support; may aid mood/sleep.
   Mechanism: Membrane fluidity; eicosanoid signaling.

2. Vitamin D3 — 1,000–2,000 IU/day (or per blood level)
   Function: Neuroimmune and muscle support; fall risk reduction.
   Mechanism: Nuclear receptor modulation.

3. Vitamin B12 (methylcobalamin) — 1,000 mcg/day (or per labs)
   Function: Myelin and nerve conduction.
   Mechanism: Cofactor in methylation and myelin synthesis.

4. Thiamine (Vitamin B1) — 100–300 mg/day if risk factors (malnutrition, diuretics, alcohol use)
   Function: Energy metabolism in brainstem circuits.
   Mechanism: Pyruvate dehydrogenase cofactor.

5. Magnesium glycinate — 200–400 mg elemental/day (renal function permitting)
   Function: Sleep quality and neuromuscular calm.
   Mechanism: NMDA modulation; GABA support.

6. Melatonin — 3–5 mg nightly (if not using as a “drug” above)
   Function: Sleep timing; reduces nocturnal episodes.
   Mechanism: MT1/MT2 receptor action on circadian clock. PMC

7. Lutein + Zeaxanthin — Lutein 10–20 mg + Zeaxanthin 2–4 mg/day
   Function: Retinal health; may sharpen visual input.
   Mechanism: Macular pigment antioxidants.

8. Coenzyme Q10 — 100–200 mg/day
   Function: Mitochondrial energy support.
   Mechanism: Electron transport chain cofactor; antioxidant.

9. N-Acetylcysteine (NAC) — 600–1,200 mg/day
   Function: Antioxidant and glutathione precursor; may aid neurorecovery.
   Mechanism: Redox modulation, glutamate regulation.

10. Curcumin (with piperine or a bioavailable form) — 500–1,000 mg/day
    Function: Anti-inflammatory support.
    Mechanism: NF-κB and cytokine modulation.

---

Regenerative / stem-cell / immune-modulating” drugs

Not standard care for PH. These are experimental neurorestorative strategies studied mainly in stroke or traumatic brain injury. Discuss only within clinical trials.

1. Mesenchymal stem cell (MSC) therapy (IV/intra-arterial)
   Investigational dose: Often 1–2 million cells/kg in trials; varies widely.
   Function/Mechanism: Paracrine release of growth and anti-inflammatory factors; potential promotion of synaptic plasticity.
   Note: Safety and efficacy are under study; not approved for PH.

2. Neural progenitor cell transplantation
   Dose: Study-specific.
   Function/Mechanism: Replace/support injured circuits; trophic factor release.
   Note: Highly experimental; neurosurgical delivery risks.

3. Erythropoietin (EPO)
   Dose in trials: Variable IV dosing early after stroke.
   Function/Mechanism: Anti-apoptotic, pro-angiogenic effects; mixed human data; thrombotic risk.

4. Cerebrolysin (porcine brain-derived peptides)
   Dose (trial regimens): 5–30 mL IV daily in cycles.
   Function/Mechanism: Proposed neurotrophic/anti-excitotoxic effects; mixed meta-analytic signals; not universally recommended.

5. Citicoline (CDP-choline)
   Dose: 500–2,000 mg/day orally.
   Function/Mechanism: Phospholipid precursor; membrane repair support; large stroke trial neutral overall, but generally safe.

6. Granulocyte Colony-Stimulating Factor (G-CSF)
   Dose in research: Varies by protocol.
   Function/Mechanism: Mobilizes bone-marrow stem cells; neuroprotective signals; mixed/negative stroke trials; leukocytosis/thrombosis risk.

---

Surgeries

Surgery is not for PH itself but may be required when a treatable structural cause is found.

1. Microsurgical resection of a midbrain or thalamic tumor/cavernous malformation
   Procedure: Craniotomy with delicate removal/biopsy using navigation and monitoring.
   Why: Decompress or eliminate the lesion causing PH and other deficits. Case literature notes improvement after resection in selected patients. PubMed

2. Endovascular coiling or surgical clipping of an aneurysm
   Procedure: Coils placed via catheter, or open surgery to place a clip.
   Why: Secure a ruptured or high-risk aneurysm (e.g., basilar-tip) linked with PH; treating the aneurysm addresses the underlying vascular injury. J-STAGE

3. Arteriovenous malformation (AVM) therapy
   Procedure: Endovascular embolization, microsurgery, or stereotactic radiosurgery.
   Why: Reduce hemorrhage risk or mass effect if an AVM near the midbrain is implicated.

4. CSF diversion (ventricular drain or shunt) if hydrocephalus is present
   Procedure: Temporary external drain or permanent shunt.
   Why: Lower pressure on brainstem circuits that may worsen hallucinations.

5. Stereotactic radiosurgery for deep lesions unsuitable for open surgery
   Procedure: Focused radiation in one or a few sessions.
   Why: Control growth or reduce hemorrhage risk of deep vascular/tumor lesions when open surgery is too risky.

---

Prevention tips

1. Control vascular risks: manage blood pressure, diabetes, cholesterol, and don’t smoke.

2. Keep a regular sleep schedule; treat sleep apnea if present. PMC

3. Use soft evening lighting and night-lights; avoid total darkness. PMC

4. Keep glasses up to date; treat eye disease promptly. EyeWiki

5. Limit evening alcohol and sedatives that fragment sleep.

6. Stay hydrated and treat infections early.

7. Exercise most days (as cleared by your clinician).

8. Simplify home visuals and remove tripping hazards.

9. Track and avoid personal triggers (stress, severe fatigue, long dark corridors).

10. Take medicines exactly as prescribed; bring a list to appointments.

---

When to see a doctor—now vs. soon

• Urgent, same-day care or ER if new hallucinations follow sudden neurologic symptoms (weakness, droopy eyelid, double vision, severe headache, imbalance), or after a head injury. A new focal lesion or stroke must be ruled out. PMC

• Prompt clinic visit if hallucinations recur, disrupt sleep or safety, or you start new psychoactive medicines.

• Follow-up with neurology/neuro-ophthalmology if you have known midbrain/thalamic lesions or prior aneurysm/AVM.

---

What to eat” and “what to avoid

1. Eat: Mediterranean-style pattern (vegetables, fruits, legumes, whole grains, olive oil). Avoid: Ultra-processed snacks high in sugar/salt that disrupt sleep and vascular health.

2. Eat: Fatty fish (salmon, sardines) 2×/week for omega-3s. Avoid: Fried/processed meats that raise vascular risk.

3. Eat: Leafy greens and colorful produce for antioxidants. Avoid: Large late-night heavy meals that worsen reflux and sleep.

4. Eat: Nuts and seeds (walnut, flax, chia). Avoid: Excess added sugars (sodas, sweets) that spike glucose.

5. Eat: Fermented dairy/yogurt if tolerated. Avoid: Excess alcohol—especially in the evening.

6. Drink: Water regularly through the day. Avoid: Severe dehydration or very high evening fluid intake that disrupts sleep.

7. Use: Herbs/spices (turmeric, ginger) in cooking. Avoid: High-caffeine drinks late afternoon/evening.

8. Choose: High-fiber whole grains. Avoid: Refined white breads/pastries.

9. Include: Protein at each meal (fish, beans, poultry). Avoid: Very high-salt foods that aggravate blood pressure.

10. Consider with clinician: Omega-3, vitamin D, B-vitamin repletion if low. Avoid without supervision: Herbal stimulants or multiple overlapping sedating supplements.

PH can fade spontaneously as the brain heals, especially when caused by small strokes or transient vascular problems; in other cases, it improves after treating the underlying structural lesion or with short-term symptomatic medication. Long-term outcomes depend on the cause and overall brain health. PubMed+1

---

Frequently asked questions

1) Is PH a mental illness?
No. PH is neurological—most often from a lesion near the midbrain/thalamus. People are usually aware the images aren’t real. EyeWiki

2) Can PH be the only sign of a brain problem?
Sometimes, yes. Case reports show PH after posterior circulation aneurysm rupture without obvious deficits—so new PH deserves medical evaluation. J-STAGE

3) How is PH different from Charles Bonnet syndrome (CBS)?
CBS stems from eye/vision loss with intact brain; PH stems from deep brain lesions and may include brainstem signs. EyeWiki

4) Why at night or in the dark?
Low light reduces visual input, increasing the brain’s tendency to “fill in”; drowsiness and REM-sleep intrusion may also play roles. ScienceDirect

5) Will PH go away on its own?
It often improves over weeks to months, especially as the cause heals or stabilizes. Some cases resolve without medication. PubMed

6) What tests are usually done?
Doctors may order MRI/MRA, eye exam, metabolic labs, and sometimes EEG to rule out other causes of visual phenomena; choices depend on the story and exam.

7) Are antipsychotics always required?
No. They’re used case-by-case for short periods when episodes are frequent or risky. Olanzapine and quetiapine helped in several reports. MeridianPubMed

8) Is melatonin helpful?
Often, yes—especially if episodes cluster at night. It can stabilize sleep timing and has supportive evidence in REM sleep behavior disorder and PH case reports. PMCPubMed

9) Can anxiety make PH worse?
Yes. Fear spikes noradrenaline, intensifying misperceptions. Calm reassurance and grounding often shorten episodes.

10) Do I need surgery?
Only if a treatable lesion (e.g., aneurysm, AVM, tumor) is found; the decision is made by neurosurgery after careful risk–benefit discussion. J-STAGEPubMed

11) Is PH related to seizures?
PH is not a seizure. However, doctors may check EEG if the story is atypical to exclude occipital seizures.

12) Can medications trigger or worsen PH?
Drugs that disturb sleep or strongly stimulate/antagonize dopamine/serotonin pathways might worsen visuals in predisposed brains; always review your list with a clinician.

13) Does improving eyesight help?
Yes—better visual input (glasses, cataract care) reduces “fill-in” errors and may lessen episodes. EyeWiki

14) Is PH dangerous?
The images themselves are not injurious, but startle reactions, falls, or delayed stroke diagnosis are the risks—hence safety steps and prompt evaluation.

15) What should caregivers do during an episode?
Stay calm, increase light, validate the person’s experience (“I know it looks real and that’s scary”), guide them to sit, hydrate, and use grounding techniques.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 20, 2025.